Feng Peng Selected Research

Colorectal Neoplasms (Colorectal Cancer)

10/2023	METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
1/2022	Prognostic Lnc-S100B-2 Affects Cell Apoptosis and Microenvironment of Colorectal Cancer through MLLT10 Signaling.
10/2021	Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
1/2021	Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
1/2020	A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
8/2019	LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
1/2018	Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study.
1/2018	An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: The FIESTA study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Peng Research Topics

Disease

78	Neoplasms (Cancer) 04/2024 - 02/2002
21	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2010
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2011
14	Carcinoma (Carcinomatosis) 10/2022 - 05/2004
13	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2014
10	Carcinogenesis 01/2024 - 01/2009
9	Infections 03/2023 - 08/2015
8	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2018
8	Lung Neoplasms (Lung Cancer) 05/2023 - 12/2004
8	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 12/2011
8	Adenocarcinoma of Lung 01/2021 - 07/2017
6	Esophageal Squamous Cell Carcinoma 12/2023 - 09/2016
6	Fibrosis (Cirrhosis) 12/2023 - 01/2014
6	Hypertension (High Blood Pressure) 01/2023 - 04/2013
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 01/2017
5	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 11/2022
5	Inflammation (Inflammations) 12/2023 - 12/2016
4	Diabetes Mellitus 11/2021 - 01/2018
4	Colonic Neoplasms (Colon Cancer) 04/2018 - 06/2005
4	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 06/2012
4	Essential Hypertension 01/2017 - 11/2002
3	Lymphatic Metastasis 04/2024 - 01/2018
3	Bacterial Infections (Bacterial Infection) 12/2023 - 02/2021
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2009
3	Cholangiocarcinoma 01/2022 - 08/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 02/2017
3	Brain Neoplasms (Brain Tumor) 12/2020 - 09/2013
3	Disease Progression 01/2020 - 08/2013
3	Hyperglycemia 06/2019 - 02/2017
2	Chronic Renal Insufficiency 03/2024 - 04/2018
2	Myocardial Infarction 01/2024 - 01/2023
2	Bone Diseases (Bone Disease) 12/2023 - 01/2023
2	Poisoning 11/2023 - 05/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2023 - 02/2015
2	Residual Neoplasm 02/2023 - 02/2015
2	Stroke (Strokes) 01/2023 - 01/2018
2	Heart Failure 01/2023 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 03/2017
2	Necrosis 09/2022 - 06/2005

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2003
10	Long Noncoding RNAIBA 01/2022 - 08/2017
9	ErbB Receptors (EGF Receptor)IBA 04/2024 - 03/2003
8	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 11/2002
7	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2011
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2005
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2016
6	AlloysIBA 08/2023 - 12/2016
6	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2016
6	VaccinesIBA 01/2020 - 02/2002
5	MagnesiumIBA 12/2023 - 12/2016
5	Small Interfering RNA (siRNA)IBA 06/2015 - 01/2009
4	Therapeutic UsesIBA 12/2023 - 12/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 02/2015
4	hydroxide ionIBA 08/2023 - 12/2016
4	Triglycerides (Triacylglycerol)IBA 11/2021 - 11/2002
4	Gefitinib (Iressa)FDA Link 12/2020 - 01/2012
4	Immunoglobulin G (IgG)IBA 09/2020 - 03/2003
4	LipidsIBA 08/2019 - 01/2018
4	Polysaccharides (Glycans)IBA 04/2018 - 04/2014
4	AntigensIBA 08/2007 - 02/2002
3	CytokinesIBA 12/2023 - 10/2011
3	Biocompatible Materials (Biomaterials)IBA 03/2023 - 04/2021
3	Messenger RNA (mRNA)IBA 09/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 12/2011
3	CateninsIBA 01/2022 - 01/2018
3	PlatinumIBA 01/2021 - 05/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2015
3	CrizotinibIBA 01/2020 - 11/2017
3	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 08/2006
3	RNA (Ribonucleic Acid)IBA 03/2019 - 02/2012
3	hepatitis B virus X proteinIBA 01/2019 - 01/2017
3	CreatinineIBA 01/2019 - 07/2014
3	LigandsIBA 01/2016 - 02/2002
3	AutoantibodiesIBA 01/2014 - 02/2002
3	Immunoglobulins (Immunoglobulin)IBA 11/2004 - 02/2002
2	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2019
2	Caspase 3 (Caspase-3)IBA 12/2023 - 01/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 01/2020
2	ImmunosorbentsIBA 12/2023 - 02/2016
2	EnzymesIBA 12/2023 - 02/2016
2	6-methyladenineIBA 10/2023 - 01/2020
2	CopperIBA 01/2023 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2022
2	OxidesIBA 01/2023 - 10/2022
2	MetalsIBA 01/2023 - 01/2017
2	nitinolIBA 10/2022 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022 - 01/2018

Therapy/Procedure

45	Therapeutics 04/2024 - 02/2002
16	Drug Therapy (Chemotherapy) 02/2023 - 12/2004
12	Radiotherapy 06/2023 - 12/2004
7	Pancreaticoduodenectomy 04/2024 - 10/2013
7	Gastrectomy 10/2022 - 01/2017
3	Immunotherapy 04/2024 - 09/2003
3	Stents 03/2024 - 09/2016
3	Liver Transplantation 04/2019 - 08/2015
2	Electrodes (Electrode) 03/2024 - 05/2015
2	Palliative Care (Palliative Therapy) 02/2023 - 09/2016
2	Semiconductors 02/2023 - 10/2022